3.20.1 html 526 509 1 true 200 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://biolargo.com/20191231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://biolargo.com/20191231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://biolargo.com/20191231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://biolargo.com/20191231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) Sheet http://biolargo.com/20191231/role/statement-consolidated-statement-of-stockholders-equity-deficit Consolidated Statement of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://biolargo.com/20191231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Business and Organization Sheet http://biolargo.com/20191231/role/statement-note-1-business-and-organization Note 1 - Business and Organization Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Lincoln Park Financing Sheet http://biolargo.com/20191231/role/statement-note-3-lincoln-park-financing Note 3 - Lincoln Park Financing Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Debt Obligations Sheet http://biolargo.com/20191231/role/statement-note-4-debt-obligations Note 4 - Debt Obligations Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Share-based Compensation Sheet http://biolargo.com/20191231/role/statement-note-5-sharebased-compensation Note 5 - Share-based Compensation Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Warrants Sheet http://biolargo.com/20191231/role/statement-note-6-warrants Note 6 - Warrants Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses Sheet http://biolargo.com/20191231/role/statement-note-7-accounts-payable-and-accrued-expenses Note 7 - Accounts Payable and Accrued Expenses Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Provision for Income Taxes Sheet http://biolargo.com/20191231/role/statement-note-8-provision-for-income-taxes- Note 8 - Provision for Income Taxes Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Noncontrolling Interest - Clyra Medical Sheet http://biolargo.com/20191231/role/statement-note-9-noncontrolling-interest-clyra-medical Note 9 - Noncontrolling Interest - Clyra Medical Notes 15 false false R16.htm 015 - Disclosure - Note 10 - BioLargo Engineering, Science and Technologies, LLC Sheet http://biolargo.com/20191231/role/statement-note-10-biolargo-engineering-science-and-technologies-llc Note 10 - BioLargo Engineering, Science and Technologies, LLC Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Business Segment Information Sheet http://biolargo.com/20191231/role/statement-note-11-business-segment-information Note 11 - Business Segment Information Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://biolargo.com/20191231/role/statement-note-12-commitments-and-contingencies Note 12 - Commitments and Contingencies Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Subsequent Events Sheet http://biolargo.com/20191231/role/statement-note-13-subsequent-events Note 13 - Subsequent Events Notes 19 false false R20.htm 019 - Disclosure - Significant Accounting Policies (Policies) Sheet http://biolargo.com/20191231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies 20 false false R21.htm 020 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies 21 false false R22.htm 021 - Disclosure - Note 3 - Lincoln Park Financing (Tables) Sheet http://biolargo.com/20191231/role/statement-note-3-lincoln-park-financing-tables Note 3 - Lincoln Park Financing (Tables) Tables http://biolargo.com/20191231/role/statement-note-3-lincoln-park-financing 22 false false R23.htm 022 - Disclosure - Note 4 - Debt Obligations (Tables) Sheet http://biolargo.com/20191231/role/statement-note-4-debt-obligations-tables Note 4 - Debt Obligations (Tables) Tables http://biolargo.com/20191231/role/statement-note-4-debt-obligations 23 false false R24.htm 023 - Disclosure - Note 5 - Share-based Compensation (Tables) Sheet http://biolargo.com/20191231/role/statement-note-5-sharebased-compensation-tables Note 5 - Share-based Compensation (Tables) Tables http://biolargo.com/20191231/role/statement-note-5-sharebased-compensation 24 false false R25.htm 024 - Disclosure - Note 6 - Warrants (Tables) Sheet http://biolargo.com/20191231/role/statement-note-6-warrants-tables Note 6 - Warrants (Tables) Tables http://biolargo.com/20191231/role/statement-note-6-warrants 25 false false R26.htm 025 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses (Tables) Sheet http://biolargo.com/20191231/role/statement-note-7-accounts-payable-and-accrued-expenses-tables Note 7 - Accounts Payable and Accrued Expenses (Tables) Tables http://biolargo.com/20191231/role/statement-note-7-accounts-payable-and-accrued-expenses 26 false false R27.htm 026 - Disclosure - Note 9 - Noncontrolling Interest - Clyra Medical (Tables) Sheet http://biolargo.com/20191231/role/statement-note-9-noncontrolling-interest-clyra-medical-tables Note 9 - Noncontrolling Interest - Clyra Medical (Tables) Tables http://biolargo.com/20191231/role/statement-note-9-noncontrolling-interest-clyra-medical 27 false false R28.htm 027 - Disclosure - Note 11 - Business Segment Information (Tables) Sheet http://biolargo.com/20191231/role/statement-note-11-business-segment-information-tables Note 11 - Business Segment Information (Tables) Tables http://biolargo.com/20191231/role/statement-note-11-business-segment-information 28 false false R29.htm 028 - Disclosure - Note 12 - Commitments and Contingencies (Tables) Sheet http://biolargo.com/20191231/role/statement-note-12-commitments-and-contingencies-tables Note 12 - Commitments and Contingencies (Tables) Tables http://biolargo.com/20191231/role/statement-note-12-commitments-and-contingencies 29 false false R30.htm 029 - Disclosure - Note 1 - Business and Organization (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-1-business-and-organization-details-textual Note 1 - Business and Organization (Details Textual) Details http://biolargo.com/20191231/role/statement-note-1-business-and-organization 30 false false R31.htm 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-tables 31 false false R32.htm 031 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Summary of Cash Balances (Details) Sheet http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-summary-of-cash-balances-details Note 2 - Summary of Significant Accounting Policies - Summary of Cash Balances (Details) Details 32 false false R33.htm 032 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Credit Concentration (Details) Sheet http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-credit-concentration-details Note 2 - Summary of Significant Accounting Policies - Credit Concentration (Details) Details 33 false false R34.htm 033 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Inventory (Details) Sheet http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-inventory-details Note 2 - Summary of Significant Accounting Policies - Inventory (Details) Details http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-tables 34 false false R35.htm 034 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Stock Options, Valuation Assumptions (Details) Sheet http://biolargo.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-stock-options-valuation-assumptions-details Note 2 - Summary of Significant Accounting Policies - Stock Options, Valuation Assumptions (Details) Details 35 false false R36.htm 035 - Disclosure - Note 3 - Lincoln Park Financing (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-3-lincoln-park-financing-details-textual Note 3 - Lincoln Park Financing (Details Textual) Details http://biolargo.com/20191231/role/statement-note-3-lincoln-park-financing-tables 36 false false R37.htm 036 - Disclosure - Note 3 - Lincoln Park Financing - Purchase Agreement (Details) Sheet http://biolargo.com/20191231/role/statement-note-3-lincoln-park-financing-purchase-agreement-details Note 3 - Lincoln Park Financing - Purchase Agreement (Details) Details 37 false false R38.htm 037 - Disclosure - Note 4 - Debt Obligations (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-4-debt-obligations-details-textual Note 4 - Debt Obligations (Details Textual) Details http://biolargo.com/20191231/role/statement-note-4-debt-obligations-tables 38 false false R39.htm 038 - Disclosure - Note 4 - Debt Obligations - Schedule of Debt (Details) Sheet http://biolargo.com/20191231/role/statement-note-4-debt-obligations-schedule-of-debt-details Note 4 - Debt Obligations - Schedule of Debt (Details) Details 39 false false R40.htm 039 - Disclosure - Note 4 - Debt Obligations - Early Conversion of Unit Notes (Details) Notes http://biolargo.com/20191231/role/statement-note-4-debt-obligations-early-conversion-of-unit-notes-details Note 4 - Debt Obligations - Early Conversion of Unit Notes (Details) Details 40 false false R41.htm 040 - Disclosure - Note 5 - Share-based Compensation (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-5-sharebased-compensation-details-textual Note 5 - Share-based Compensation (Details Textual) Details http://biolargo.com/20191231/role/statement-note-5-sharebased-compensation-tables 41 false false R42.htm 041 - Disclosure - Note 5 - Share-based Compensation - Stock Options (Details) Sheet http://biolargo.com/20191231/role/statement-note-5-sharebased-compensation-stock-options-details Note 5 - Share-based Compensation - Stock Options (Details) Details 42 false false R43.htm 042 - Disclosure - Note 5 - Share-based Compensation - Stock Options Issued Under the 2007 Equity Incentive Plan (Details) Sheet http://biolargo.com/20191231/role/statement-note-5-sharebased-compensation-stock-options-issued-under-the-2007-equity-incentive-plan-details Note 5 - Share-based Compensation - Stock Options Issued Under the 2007 Equity Incentive Plan (Details) Details 43 false false R44.htm 043 - Disclosure - Note 6 - Warrants (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-6-warrants-details-textual Note 6 - Warrants (Details Textual) Details http://biolargo.com/20191231/role/statement-note-6-warrants-tables 44 false false R45.htm 044 - Disclosure - Note 6 - Warrants - Warrants Outstanding (Details) Sheet http://biolargo.com/20191231/role/statement-note-6-warrants-warrants-outstanding-details Note 6 - Warrants - Warrants Outstanding (Details) Details 45 false false R46.htm 045 - Disclosure - Note 6 - Warrants - Assumptions Used to Determine Fair Value of Warrants (Details) Sheet http://biolargo.com/20191231/role/statement-note-6-warrants-assumptions-used-to-determine-fair-value-of-warrants-details Note 6 - Warrants - Assumptions Used to Determine Fair Value of Warrants (Details) Details 46 false false R47.htm 046 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Sheet http://biolargo.com/20191231/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details Note 7 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Details 47 false false R48.htm 047 - Disclosure - Note 8 - Provision for Income Taxes (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-8-provision-for-income-taxes-details-textual Note 8 - Provision for Income Taxes (Details Textual) Details http://biolargo.com/20191231/role/statement-note-8-provision-for-income-taxes- 48 false false R49.htm 048 - Disclosure - Note 9 - Noncontrolling Interest - Clyra Medical (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-9-noncontrolling-interest-clyra-medical-details-textual Note 9 - Noncontrolling Interest - Clyra Medical (Details Textual) Details http://biolargo.com/20191231/role/statement-note-9-noncontrolling-interest-clyra-medical-tables 49 false false R50.htm 049 - Disclosure - Note 9 - Noncontrolling Interest - Clyra Medical Common and Preferred Shares Outstanding (Details) Sheet http://biolargo.com/20191231/role/statement-note-9-noncontrolling-interest-clyra-medical-common-and-preferred-shares-outstanding-details Note 9 - Noncontrolling Interest - Clyra Medical Common and Preferred Shares Outstanding (Details) Details 50 false false R51.htm 050 - Disclosure - Note 10 - BioLargo Engineering, Science and Technologies, LLC (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-10-biolargo-engineering-science-and-technologies-llc-details-textual Note 10 - BioLargo Engineering, Science and Technologies, LLC (Details Textual) Details http://biolargo.com/20191231/role/statement-note-10-biolargo-engineering-science-and-technologies-llc 51 false false R52.htm 051 - Disclosure - Note 11 - Business Segment Information (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-11-business-segment-information-details-textual Note 11 - Business Segment Information (Details Textual) Details http://biolargo.com/20191231/role/statement-note-11-business-segment-information-tables 52 false false R53.htm 052 - Disclosure - Note 11 - Business Segment Information - Segment Information (Details) Sheet http://biolargo.com/20191231/role/statement-note-11-business-segment-information-segment-information-details Note 11 - Business Segment Information - Segment Information (Details) Details 53 false false R54.htm 053 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-12-commitments-and-contingencies-details-textual Note 12 - Commitments and Contingencies (Details Textual) Details http://biolargo.com/20191231/role/statement-note-12-commitments-and-contingencies-tables 54 false false R55.htm 054 - Disclosure - Note 12 - Commitments and Contingencies - Minimum Lease Payments (Details) Sheet http://biolargo.com/20191231/role/statement-note-12-commitments-and-contingencies-minimum-lease-payments-details Note 12 - Commitments and Contingencies - Minimum Lease Payments (Details) Details 55 false false R56.htm 055 - Disclosure - Note 13 - Subsequent Events (Details Textual) Sheet http://biolargo.com/20191231/role/statement-note-13-subsequent-events-details-textual Note 13 - Subsequent Events (Details Textual) Details http://biolargo.com/20191231/role/statement-note-13-subsequent-events 56 false false All Reports Book All Reports blgo-20191231.xml blgo-20191231.xsd blgo-20191231_cal.xml blgo-20191231_def.xml blgo-20191231_lab.xml blgo-20191231_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true